These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 36903446

  • 21. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
    Li X, Yu H, Liang L, Bi Z, Wang Y, Gao S, Wang M, Li H, Miao Y, Deng R, Ma L, Luan J, Li S, Liu M, Lin J, Zhou H, Yang C.
    Biochem Pharmacol; 2020 Aug; 178():114097. PubMed ID: 32535102
    [Abstract] [Full Text] [Related]

  • 22. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
    Chen YL, Zhang X, Bai J, Gai L, Ye XL, Zhang L, Xu Q, Zhang YX, Xu L, Li HP, Ding X.
    Cell Death Dis; 2013 Jun 13; 4(6):e665. PubMed ID: 23764846
    [Abstract] [Full Text] [Related]

  • 23. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
    Boutanquoi PM, Burgy O, Beltramo G, Bellaye PS, Dondaine L, Marcion G, Pommerolle L, Vadel A, Spanjaard M, Demidov O, Mailleux A, Crestani B, Kolb M, Garrido C, Goirand F, Bonniaud P.
    Eur Respir J; 2020 Jun 13; 55(6):. PubMed ID: 32184320
    [Abstract] [Full Text] [Related]

  • 24. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
    Tao L, Cao J, Wei W, Xie H, Zhang M, Zhang C.
    Int Immunopharmacol; 2017 Jun 13; 47():38-46. PubMed ID: 28364627
    [Abstract] [Full Text] [Related]

  • 25. S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function.
    Xiong W, Chen S, Xiang H, Zhao S, Xiao J, Li J, Liu Y, Shu Z, Ouyang J, Zhang J, Liu H, Wang X, Zou H, Chen Y, Chen A, Lu H.
    Pulm Pharmacol Ther; 2023 Aug 13; 81():102228. PubMed ID: 37295666
    [Abstract] [Full Text] [Related]

  • 26. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
    Li A, Xiao X, Feng ZL, Chen X, Liu LJ, Lin LG, Lu JJ, Zhang LL.
    Toxicol Appl Pharmacol; 2020 Jan 15; 389():114882. PubMed ID: 31953203
    [Abstract] [Full Text] [Related]

  • 27. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F, Mou C.
    Med Sci Monit; 2020 Feb 05; 26():e919739. PubMed ID: 32019905
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of Raf1 ameliorates bleomycin-induced pulmonary fibrosis through attenuation of TGF-β1 signaling.
    Li S, Liu J, Tan J, Li L, Kaltreider MJ, Zhao J, Kass DJ, Shang D, Zhao Y.
    Am J Physiol Lung Cell Mol Physiol; 2018 Aug 01; 315(2):L241-L247. PubMed ID: 29722566
    [Abstract] [Full Text] [Related]

  • 29. N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear translocation of Smad2/3.
    Nakamura H, Zhou Y, Sakamoto Y, Yamazaki A, Kurumiya E, Yamazaki R, Hayashi K, Kasuya Y, Watanabe K, Kasahara J, Takabatake M, Tatsumi K, Yoshino I, Honda T, Murayama T.
    Biomed Pharmacother; 2023 Apr 01; 160():114405. PubMed ID: 36804125
    [Abstract] [Full Text] [Related]

  • 30. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H, Lv Z, Liu S, Zhang L, Huang K, Gao S, Gan W, Liu X, Zhang S, Helian K, Li X, Zhou H, Yang C.
    J Pharm Pharmacol; 2020 Jan 01; 72(1):44-55. PubMed ID: 31659758
    [Abstract] [Full Text] [Related]

  • 31. Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis.
    Zeng C, Yue H, Wang C, Ju X, Wang T, Fu X, Zhou Q, Zhang H, He L, Yu J, Wang Y.
    J Transl Med; 2024 Oct 07; 22(1):910. PubMed ID: 39375691
    [Abstract] [Full Text] [Related]

  • 32. The antifibrotic effect of pheretima protein is mediated by the TGF-β1/Smad2/3 pathway and attenuates inflammation in bleomycin-induced idiopathic pulmonary fibrosis.
    Li S, Yang Q, Chen F, Tian L, Huo J, Meng Y, Tang Q, Wang W.
    J Ethnopharmacol; 2022 Mar 25; 286():114901. PubMed ID: 34890730
    [Abstract] [Full Text] [Related]

  • 33. Evogliptin attenuates bleomycin-induced lung fibrosis via inhibiting TGF-β/Smad signaling in fibroblast.
    Ba YD, Sun JH, Zhao XX.
    Eur Rev Med Pharmacol Sci; 2020 Oct 25; 24(20):10790-10798. PubMed ID: 33155239
    [Abstract] [Full Text] [Related]

  • 34. Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis.
    Wang D, Gong L, Li Z, Chen H, Xu M, Rong R, Zhang Y, Zhu Q.
    J Ethnopharmacol; 2021 Dec 05; 281():114522. PubMed ID: 34391863
    [Abstract] [Full Text] [Related]

  • 35. 5,7,3',4'-Tetramethoxyflavone suppresses TGF-β1-induced activation of murine fibroblasts in vitro and ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Cheng WC, Chen PY, Zhang X, Chang YK, Tan KT, Lin TCC.
    Immunopharmacol Immunotoxicol; 2024 Aug 05; 46(4):496-508. PubMed ID: 38951964
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R, Wang X, Zhao X, Song N, Zhu J, Wang J, Wang J, Xia C, Chen Y, Zhu D, Shen L.
    Sci Rep; 2016 Oct 24; 6():35696. PubMed ID: 27774992
    [Abstract] [Full Text] [Related]

  • 39. Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice.
    Guo J, Fang Y, Jiang F, Li L, Zhou H, Xu X, Ning W.
    Eur J Pharmacol; 2019 Dec 01; 864():172712. PubMed ID: 31586469
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.